ARKB | YBTC | ARKB / YBTC | |
Gain YTD | 16.854 | 19.688 | 86% |
Net Assets | 5.19B | 227M | 2,285% |
Total Expense Ratio | 0.21 | 0.96 | 22% |
Turnover | N/A | N/A | - |
Yield | 0.00 | 43.91 | - |
Fund Existence | 1 year | 1 year | - |
ARKB | YBTC | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago84% | 4 days ago82% |
Momentum ODDS (%) | 4 days ago90% | 4 days ago90% |
MACD ODDS (%) | 4 days ago90% | 4 days ago90% |
TrendWeek ODDS (%) | 4 days ago90% | 4 days ago90% |
TrendMonth ODDS (%) | 4 days ago90% | 4 days ago90% |
Advances ODDS (%) | 12 days ago90% | 4 days ago90% |
Declines ODDS (%) | 10 days ago87% | 17 days ago84% |
BollingerBands ODDS (%) | 21 days ago90% | N/A |
Aroon ODDS (%) | 4 days ago90% | 4 days ago90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBH | 157.70 | 0.23 | +0.15% |
VanEck Biotech ETF | |||
LOCT | 23.85 | 0.01 | +0.04% |
Innovator Premium Income 15 Buf ETF -Oct | |||
PBAU | 28.16 | N/A | N/A |
PGIM S&P 500 Buffer 20 ETF - Aug | |||
QLTA | 47.57 | -0.11 | -0.23% |
iShares Aaa - A Rated Corporate Bond ETF | |||
IFGL | 22.76 | -0.12 | -0.52% |
iShares International Dev Real Est ETF |